• FEATURES
  • PRICING
  • MARKETPLACE
  • CASE STUDIES
  • BLOG
  • New Customer: Dana-Farber Cancer Institute (USA) adopts OpenSpecimen

    We are pleased to announce that the Dana-Farber Cancer Institute (Boston, USA) will be adopting OpenSpecimen as their biobanking LIMS.

    The project involves migration of data caTissue, training, configuration and a few enhancements.

    We are delighted to have them on board and look forward to working with them.

    Click here to see our full customer list.